Previous Close | 70.61 |
Open | 69.10 |
Bid | 70.51 x N/A |
Ask | 70.58 x N/A |
Day's Range | 69.44 - 70.89 |
52 Week Range | 56.60 - 103.65 |
Volume | |
Avg. Volume | 557,122 |
Market Cap | 9.11B |
Beta (5Y Monthly) | 0.88 |
PE Ratio (TTM) | 41.23 |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | 2.00 (2.84%) |
Ex-Dividend Date | May 24, 2023 |
1y Target Est | N/A |
BEIJING, China, April 26, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- Sino Biological, Inc.("Sino Biological" or the "Company”), a biotechnology company listed on the Shenzhen stock exchange subsidiary ChiNext (SZSE: 301047), specializing in biological research reagents and related technical contract research services, has successfully concluded its acquisition of Vancouver-based Canadian biotechnology company SignalChem Biotech Inc. (“SCB” or "SignalChem”). Sino Biological has acquired 100% of
Sino Biological and Rapid Novor partner to offer combined antibody development and sequencing services BEIJING, China, March 14, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire — Sino Biological, Inc. (“Sino Biological” or the “Company”), a biotechnology company listed on the Shenzhen stock exchange subsidiary ChiNext (SZSE: 301047), which provides biological research reagents and related technical contract research services, is pleased to announce the formation of a services partnership with Toronto,
Sino Biological C4B Sino Biological Center for Bioprocessing HOUSTON, TX, Oct. 09, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire — Sino Biological, Inc. (“Sino Biological” or the “Company”), a biotechnology company listed on the Shenzhen stock exchange subsidiary ChiNext (SZSE: 301047), which provides biological research reagents and related technical contract research services, is pleased to announce the formal opening of its new Center for Bioprocessing (C4B) in Houston, Texas USA at Levit Green,